TherapeuticsMD
Stock Forecast, Prediction & Price Target

TherapeuticsMD Financial Estimates

TherapeuticsMD Revenue Estimates

TherapeuticsMD EBITDA Estimates

TherapeuticsMD Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027
Revenue
 
% change YoY
$86.95M
 
N/A
$69.96M
 
-19.53%
$1.30M
 
-98.13%
Avg: $9.2M
Low: $9.2M
High: $9.2M
avg. 606.60%
Avg: $9.3M
Low: $9.3M
High: $9.3M
avg. 1.08%
Avg: $9.5M
Low: $9.5M
High: $9.5M
avg. 2.15%
Net Income
 
% change YoY
$-205.60M
 
N/A
$111.99M
 
154.47%
$-10.27M
 
-109.17%
Avg: $1.8M
Low: $1.67M
High: $1.67M
avg. 117.51%
Avg: $1.77M
Low: $1.77M
High: $1.77M
avg. -1.39%
Avg: $1.98M
Low: $1.98M
High: $1.98M
avg. 11.76%
EBITDA
 
% change YoY
$-135.40M
 
N/A
$21.32M
 
115.75%
$-8.40M
 
-139.38%
Avg: $-6.79M
Low: $-6.79M
High: $-6.79M
avg. 19.06%
Avg: $-6.87M
Low: $-6.87M
High: $-6.87M
avg. -1.08%
Avg: $-7.02M
Low: $-7.02M
High: $-7.02M
avg. -2.15%
EPS
 
% change YoY
-$25.83
 
N/A
-$10.35
 
59.93%
-$0.55
 
94.68%
Avg: $0.16
Low: $0.16
High: $0.16
avg. 129.09%
Avg: $0.17
Low: $0.17
High: $0.17
avg. 6.25%
Avg: $0.19
Low: $0.19
High: $0.19
avg. 11.76%
Operating Expenses
 
% change YoY
$207.88M
 
N/A
$57.90M
 
-72.14%
$9.82M
 
-83.03%
Avg: $30.27M
Low: $30.27M
High: $30.27M
avg. 208.19%
Avg: $30.60M
Low: $30.60M
High: $30.60M
avg. 1.08%
Avg: $31.26M
Low: $31.26M
High: $31.26M
avg. 2.15%

FAQ

What is TherapeuticsMD stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 42.62% in 2025-2027.

We have gathered data from 1 analysts. Their low estimate is 1.67M, average is 1.8M and high is 1.67M.

What is TherapeuticsMD stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 203.28% in 2025-2027.

We have gathered data from 1 analysts. Their low revenue estimate is $9.2M, average is $9.2M and high is $9.2M.

What is TherapeuticsMD stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 49.03% in 2025-2027.

We have gathered data from 1 analysts. Their low earnings per share estimate is $0.16, average is $0.16 and high is $0.16.